Evidence map›Paper›PMID 28129045›Full record

ReviewNutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition2017

Emerging Clinical Benefits of New-Generation Fat Emulsions in Preterm Neonates.

Gregory Guthrie, Muralidhar Premkumar, Douglas G Burrin

Open access · greenAbstract readReview
In one paragraph

Review in Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. New-generation intravenous fat emulsions and bronchopulmonary dysplasia in preterm infants: a systematic review and meta-analysis.Journal of perinatology : official journal of the California Perinatal Association · 2020
    Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Suppression of IRE1Gastroenterology research and practice · 2020
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Gregory Guthrie1 USDA/ARS Children's Nutrition Research Center, Section of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.
Muralidhar Premkumar2 Section of Neonatology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.
Douglas G Burrin1 USDA/ARS Children's Nutrition Research Center, Section of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.
Children's Nutrition Research Center at Baylor College of Medicine · USZero to Three · US

Funding

Research Training in Pediatrics GastroenterolgyT32DK007664 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI DOUGLAS G BURRIN · 1991 to 2026
$8.4M
Regulation of Hepatic Metabolic Function by Parenteral NutritionR01DK094616 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI BURRIN, DOUGLAS G · 2013 to 2022
$2.3M
NIDDK NIH HHS R01 DK094616NIDDK NIH HHS T32 DK007664
6 · The paper itself

Abstract

Soybean oil-based intravenous fat emulsions (IVFEs) have been the predominant parenteral nutrition IVFE used in the United States for neonates over the past 45 years. Even though this emulsion has proven useful in supplying infants with energy for growth and essential fatty acids, there have been concerns over its composition in the development of several morbidities, ranging from sepsis to liver disease, bronchopulmonary dysplasia, and impaired neurodevelopment and growth. The exact mechanisms that drive these morbidities in preterm infants are multifactorial, but potential contributors include high ω-6 (n-6) fatty acid composition, low docosahexaenoic acid and antioxidant supplementation, and the presence of potentially harmful nonnutritive components (eg, phytosterols). To address these issues, new-generation IVFEs with various types and amounts of fat have been developed containing greater amounts of the medium-chain fatty acids, long-chain polyunsaturated fatty acid, docosahexaenoic acid, lower concentrations of ω-6 polyunsaturated fatty acids, supplemental vitamin E, and low or negligible amounts of phytosterols. This review examines the clinical outcomes associated with different morbidities of parenteral nutrition in neonates who have received either soybean oil-based or new-generation IVFEs and addresses whether the proposed benefits of new-generation IVFEs have improved outcomes in the neonatal population.

Indexed as

Bronchopulmonary DysplasiaChemical and Drug Induced Liver InjuryChild DevelopmentDocosahexaenoic AcidsFat Emulsions, IntravenousFatty Acids, Omega-6HumansInfant, NewbornInfant, PrematureMeta-Analysis as TopicNeurodevelopmental DisordersPhytosterolsRandomized Controlled Trials as TopicRisk FactorsSepsisSoybean OilDocosahexaenoic AcidsFat Emulsions, IntravenousFatty Acids, Omega-6PhytosterolsSoybean OilTriglyceridesbronchopulmonary dysplasiafish oilsintravenous fat emulsionsmedium chain triglyceridesneurodevelopmentolive oilparenteral nutritionparenteral nutrition associated liver diseasepremature infantssepsissoybean oil

Identifiers

PMID28129045
PMCPMC8319959
OpenAlexW2581605766

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.